Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Diffusion Tensor Imaging × Breast × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 74 Cyclophosphamide 59 Capecitabine 57 Docetaxel 53 Paclitaxel 52 Letrozole 43 Fulvestrant 41 Carboplatin 35 Lapatinib 33 Doxorubicin 32 pembrolizumab 31 Vinorelbine 28 Bevacizumab 28 exemestane 25 Anastrozole 25 Tamoxifen 21 Gemcitabine 20 Albumin-Bound Paclitaxel 20 Radiotherapy 17 pertuzumab 15 palbociclib 14 Taxes 14 Everolimus 14 atezolizumab 13 Magnetic Resonance Spectroscopy 13 Epirubicin 13 130-nm albumin-bound paclitaxel 13 eribulin 12 Goserelin 12 Ado-Trastuzumab Emtansine 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01910298 2019-12-04

ESSBR

LifeCell

Phase NA Terminated

131 enrolled 14 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡